Navigation Links
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Date:4/24/2012

DURHAM, N.C., April 24, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that it has secured a $25 million Series D financing to support the commencement of its Phase 3 ADAPT study in patients with newly diagnosed, metastatic renal cell carcinoma (mRCC) in mid-2012. The financing was led by Forbion Capital and included other existing investors, including TVM Capital, Lumira Capital, Intersouth Partners, Caisse de depot et placement du Quebec, Morningside Group, and Aurora Funds. Argos's Arcelis™ immunotherapy, AGS-003, has also been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with mRCC.  The international Phase 3 ADAPT study is expected to commence in mid-2012 under a revised Special Protocol Assessment (SPA) agreement with the FDA. This pivotal study will evaluate the addition of AGS-003 to standard therapy versus standard therapy alone.

"With this latest round of financing Argos is well positioned to execute its business strategy and move forward with the planned Phase 3 ADAPT study of its lead product candidate, AGS-003," said Jeff Abbey, president and chief executive officer of Argos. "We recently presented updated results at the 2012 ASCO Genitourinary Cancers Symposium from a Phase 2 study of AGS-003 demonstrating prolonged survival in newly diagnosed, metastatic RCC patients.  Importantly, we also demonstrated that our intended mechanism of action, the induction of memory T cells, significantly correlated with improved overall survival.  The Phase 3 ADAPT study is designed to confirm these positive results and demonstrate that AGS-003 may be an effective, safe and readily combinable therapeutic option for patients with metastatic RCC."

Charles Nicolette, Ph.D., chief scientific officer and vice president of research and development of Argos, said, "The Fast Track designation by the FDA recogniz
'/>"/>

SOURCE Argos Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
4. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
5. Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
6. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
7. Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
(Date:8/21/2014)... 2014   Royal Philips (NYSE: ... has received 510(k) clearance from the U.S. Food ... application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through ... with pre-procedural, high-precision positioning to treat aortic stenosis ... is available as part of Philips IntelliSpace ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... LAKES, N.J., Oct. 4, 2011 BD (Becton, Dickinson and ... will conduct a live webcast of its fourth fiscal quarter ... November 2, 2011, at 8:00 a.m. (ET).  BD will issue ... The webcast of the conference call, along with ...
... LONDON, October 4, 2011 Taking place ... Grand, Berlin, Germany European Medical Device Technology ... executives in Europe,s medical device sector, today announced the ... for Medical Devices the only conference this year providing ...
Cached Medicine Technology:EMDT Launches New Specialist Conference on Managing Regulatory Change for Medical Devices 2
(Date:8/21/2014)... 2014 BambooIndustry.com is an internationally well-known ... has recently unveiled its new collection of elegant ... for customers who are looking for high quality floorings ... offered with great savings (up to 29 percent off). ... these cheap products. , The company’s bamboo flooring ...
(Date:8/21/2014)... 2014 Living in a quality residential ... comes along with it. A quality Home Owners Association ... amenities are available. , Simpson Mill ... and Community Association Management, LLC made a recent investment ... to provide an additional amenity for their neighborhood. , ...
(Date:8/21/2014)... 2014 Recently, Van Uden Center ... Alternative medicine is on the rise and much ... to The Fiscal Times, young people are becoming ... medicine. , The Fiscal Times published an article ... embracing alternative medicine. The article can be found ...
(Date:8/21/2014)... of chronic kidney disease patients may be a strong ... study in the Journal of the American Society ... Johns Hopkins Bloomberg School of Public Health assert that ... subclinical atherosclerosis in predicting the risk of heart disease ... of all patients with chronic kidney disease (CKD) die ...
(Date:8/21/2014)... appear to have better survival if they are ... Uchechukwu C. Megwalu, M.D., M.P.H., of the Ichan ... and colleagues. , Background: Approximately 11,000 to 13,000 ... and squamous cell carcinoma accounts for the vast ... surgical removal of the larynx with postoperative radiation ...
Breaking Medicine News(10 mins):Health News:Buy Elegant Bamboo Floorings from Internationally Well-known Supplier BambooIndustry.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2
... R. Morrissey, CAO of Reddy Solutions Inc., announced today that RSI has ... facility located at 200 Arizona Avenue, N.E., Ste. 200, Atlanta, GA ... ... Morrissey, CAO of Reddy Solutions Inc., announced today that RSI has completed ...
... Dec. 6 Greg Grunberg -- film and television actor,and ... real life hero, his,12-year-old son, Jake, who has been living ... joined by Epilepsy Advocates,from around the country at the L.I.V.E. ... provide support to the community of people living with,epilepsy in ...
... ago today, Lou Hawthorne got a call from a biotech lab ... owner of the very first clone of a pet dog, his ... of Missy, is a happy, healthy puppy living the good life ... resemblance to Missy, but her coat feels the same, and she ...
... be left untreated, depending on man,s age , , FRIDAY, Dec. ... prompt an understandable feeling of dread, but patients actually have ... the disease, medical experts say. , There are so many ... strongly when weighing various procedures. In fact, a growing number ...
... for individually underwritten life insurance was down -1.9% in November ... Year to date (YTD) U.S. and Canadian activity remained ... November,s activity was off -0.9% as compared to October ... application activity was down -1.8% in November year-over-year, all ages ...
... Sunrise Senior Living, Inc.,(NYSE: SRZ ) today ... the refinancing of the existing debt of one of its,joint ... yesterday by Ventas, Inc., a venture owned 85 percent by,Ventas ... Mac, secured by eight senior housing communities managed by Sunrise,aggregating ...
Cached Medicine News:Health News:RSI Expands into New State-of-the-Art Facility 2Health News:Cloned Canine Celebrates Her 1st Birthday 2Health News:Treatment Options Are Many for Prostate Cancer 2Health News:Treatment Options Are Many for Prostate Cancer 3Health News:MIB Life Index Reports North American Life Insurance Activity Off 1.9% in November 2Health News:Sunrise Receives Proceeds from Venture Refinancing 2Health News:Sunrise Receives Proceeds from Venture Refinancing 3
Triangle shape (3.0mm long) Tip with Sliding Inner Shaft, Squeeze Activates Shaft to Punch; overall length 130mm, in stainless steel...
Very fine, blunt tip....
... e.cam single-detector system offers general ... access for gurneys and wheelchairs. ... clinically versatile open gantry, caudal/cephalic ... contouring for SPECT and whole ...
Sharp diamond shaped double blade in stainless steel....
Medicine Products: